mdm2 Gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line

被引:33
作者
Kondo, S
Kondo, Y
Hara, H
Kaakaji, R
Peterson, JW
Morimura, T
Takeuchi, J
Barnett, GH
机构
[1] CLEVELAND CLIN FDN,DEPT NEUROSCI NC3,CLEVELAND,OH 44195
[2] NATL UTANO HOSP,DEPT NEUROSURG,UKYO KU,KYOTO 616,JAPAN
[3] NATL UTANO HOSP,DEPT CLIN RES CTR,UKYO KU,KYOTO 616,JAPAN
关键词
mdm2; mdr; 1; P-glycoprotein; chemotherapy; glioma;
D O I
10.1038/bjc.1996.527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The overexpression of the multidrug resistance (mdr1) gene and its product, P-glycoprotein (P-gp), is thought to limit the successful chemotherapy of human rumours. The mechanism by which mdr1 gene and P-gp are overexpressed in human tumours, however, is not yet clear. In this report, we show that the mdm2 (murine double minute 2) gene induced the expression of the mdr1 gene and P-gp in human glioblastoma U87-MG cells. which did not express the MDM2 protein or P-gp. The mdm2 gene, in addition, conferred the resistance of U87-MG cells to the apoptotic cell death induced by etoposide (VP-16) or doxorubicin. Furthermore, treatment with mdm2 antisense oligonucleotides inhibited the expression of P-gp in MDM2-expressing U87-MG cells. These findings suggest that the mdma gene may play an important role in the development of MDR phenotype in human tumours.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 42 条
  • [1] THE MULTIDRUG RESISTANCE (MDR1) GENE-PRODUCT FUNCTIONS AS AN ATP CHANNEL
    ABRAHAM, EH
    PRAT, AG
    GERWECK, L
    SENEVERATNE, T
    ARCECI, RJ
    KRAMER, R
    GUIDOTTI, G
    CANTIELLO, HF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 312 - 316
  • [2] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
    BARAK, Y
    JUVEN, T
    HAFFNER, R
    OREN, M
    [J]. EMBO JOURNAL, 1993, 12 (02) : 461 - 468
  • [3] MOLECULAR ANALYSIS AND CHROMOSOMAL MAPPING OF AMPLIFIED GENES ISOLATED FROM A TRANSFORMED MOUSE 3T3-CELL LINE
    CAHILLYSNYDER, L
    YANGFENG, T
    FRANCKE, U
    GEORGE, DL
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1987, 13 (03) : 235 - 244
  • [4] REVERSAL OF MULTIDRUG RESISTANCE
    CHABNER, BA
    WILSON, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) : 4 - 6
  • [5] P-GLYCOPROTEIN EXPRESSION AS A PREDICTOR OF THE OUTCOME OF THERAPY FOR NEUROBLASTOMA
    CHAN, HSL
    HADDAD, G
    THORNER, PS
    DEBOER, G
    LIN, YP
    ONDRUSEK, N
    YEGER, H
    LING, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) : 1608 - 1614
  • [6] MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53
    CHIN, KV
    UEDA, K
    PASTAN, I
    GOTTESMAN, MM
    [J]. SCIENCE, 1992, 255 (5043) : 459 - 462
  • [7] CLONAL P53 MUTATION IN PRIMARY CERVICAL-CANCER - ASSOCIATION WITH HUMAN-PAPILLOMAVIRUS-NEGATIVE TUMORS
    CROOK, T
    WREDE, D
    TIDY, JA
    MASON, WP
    EVANS, DJ
    VOUSDEN, KH
    [J]. LANCET, 1992, 339 (8801) : 1070 - 1073
  • [8] THE 3 MOUSE MULTIDRUG RESISTANCE (MDR) GENES ARE EXPRESSED IN A TISSUE-SPECIFIC MANNER IN NORMAL MOUSE-TISSUES
    CROOP, JM
    RAYMOND, M
    HABER, D
    DEVAULT, A
    ARCECI, RJ
    GROS, P
    HOUSMAN, DE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) : 1346 - 1350
  • [9] TUMORIGENIC POTENTIAL ASSOCIATED WITH ENHANCED EXPRESSION OF A GENE THAT IS AMPLIFIED IN A MOUSE-TUMOR CELL-LINE
    FAKHARZADEH, SS
    TRUSKO, SP
    GEORGE, DL
    [J]. EMBO JOURNAL, 1991, 10 (06) : 1565 - 1569
  • [10] THE MDM-2 ONCOGENE CAN OVERCOME WILD-TYPE P53 SUPPRESSION OF TRANSFORMED-CELL GROWTH
    FINLAY, CA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) : 301 - 306